# Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure

> **NCT01920074** · PHASE4 · WITHDRAWN · sponsor: **Forest Laboratories**

## Conditions studied

- Anal Fissure

## Interventions

- **DRUG:** Nitroglycerin Ointment 0.4%

## Key facts

- **NCT ID:** NCT01920074
- **Lead sponsor:** Forest Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-06
- **Primary completion:** 2015-03
- **Final completion:** 2015-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study stopped due to study enrollment challenges that impacted the feasibility of conducting the study.
- **Last updated:** 2015-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01920074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01920074, "Pharmacokinetic,Safety and Exploratory Efficacy of RECTIV® in Adolescents With Chronic Anal Fissure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01920074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*